{"gene":"CLN8","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":1999,"finding":"CLN8 encodes a novel putative transmembrane protein of 286 amino acids; a missense mutation (R24G) in human EPMR patients and a 1-bp insertion causing frameshift/truncation in mnd mice were identified as disease-causing mutations in orthologous CLN8 genes.","method":"Positional cloning, sequence analysis, mutation screening","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1 — positional cloning with mutation identification in both human and mouse orthologs, foundational paper with 234 citations","pmids":["10508524"],"is_preprint":false},{"year":2000,"finding":"CLN8 protein is an ER-resident transmembrane protein (~33 kDa) that recycles between the ER and ER-Golgi intermediate compartment (ERGIC); the C-terminal KKRP motif functions as an ER retrieval signal, and mutation of this signal redirects CLN8 to the Golgi apparatus.","method":"Western blotting, pulse-chase analysis, confocal immunofluorescence microscopy with organelle-specific antibodies, site-directed mutagenesis of KKRP signal","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including mutagenesis of retrieval signal with functional localization readout","pmids":["10861296"],"is_preprint":false},{"year":2002,"finding":"CLN8 is identified as a member of the TLC (TRAM-LAG1-CLN8) domain family, related to yeast Lag1p and mammalian TRAM, implicating the protein in ceramide synthesis, lipid regulation, or protein translocation at the ER.","method":"Bioinformatic sequence analysis and domain family identification","journal":"Trends in biochemical sciences","confidence":"Low","confidence_rationale":"Tier 4 — computational/bioinformatic prediction only","pmids":["12151215"],"is_preprint":false},{"year":2004,"finding":"CLN8 localizes to the ER in mouse hippocampal primary neurons; CLN8 shows basolateral targeting in polarized epithelial CaCo-2 cells; endogenous mouse Cln8 is found in light membrane fractions distinct from ER in brain fractionation; disease mutations do not alter intracellular localization of CLN8 in neuronal or non-neuronal cells.","method":"Semliki Forest virus-mediated expression, immunofluorescence microscopy with subcellular markers, subcellular fractionation of mouse brain tissue","journal":"Journal of neuroscience research","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization in neurons with fractionation, but single lab","pmids":["15160397"],"is_preprint":false},{"year":2009,"finding":"CLN8 plays a role in cell proliferation during neuronal differentiation and in protection against cell death; expression of patient-mutation CLN8 proteins in neuronal cell models and gene silencing both impaired proliferation and increased cell death during neuronal differentiation.","method":"Overexpression of wild-type and mutant CLN8 in neuronal cell models, siRNA gene silencing, cell proliferation and cell death assays","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 — KD/OE with defined cellular phenotype validated by two complementary approaches","pmids":["19431184"],"is_preprint":false},{"year":2011,"finding":"CLN8-deficient (CLN8−/−) cells have decreased ceramide synthase activity and reduced C16/C18:0/C24:0/C24:1 ceramide species; CLN8 protein functionally complements CLN5-deficient cells, correcting growth and apoptosis defects; CLN8 protein was found to interact with ceramide synthase complex.","method":"Mass spectrometry-based ceramide species quantification, co-immunoprecipitation, complementation assays in CLN5-deficient fibroblasts","journal":"Electrophoresis","confidence":"Medium","confidence_rationale":"Tier 2-3 — co-IP and functional complementation with MS quantification, single lab","pmids":["23160995"],"is_preprint":false},{"year":2011,"finding":"In Cln8mnd hippocampal neurons, clearance of large Ca2+ loads is inefficient due to impaired mitochondrial Ca2+ uptake; neither SERCA-mediated ER Ca2+ uptake nor plasma membrane Ca2+ extrusion is affected by the Cln8 mutation.","method":"Patch clamp electrophysiology, fluorescence Ca2+ imaging, caged Ca2+ photolysis in hippocampal slices and cultured neurons","journal":"Cell calcium","confidence":"Medium","confidence_rationale":"Tier 2 — multiple electrophysiological and imaging methods in Cln8mnd mouse neurons with specific mechanistic dissection","pmids":["21917311"],"is_preprint":false},{"year":2012,"finding":"CLN8 protein interacts with VAPA, c14orf1/hERG28, STX8, GATE16, BNIP3, and BNIP3L; interactions with VAPA and GATE16 were validated by co-immunoprecipitation and co-localization assays in mammalian cells and confirmed in CNS tissues.","method":"Split-ubiquitin membrane yeast two-hybrid (MYTH) screen with human brain cDNA library, co-immunoprecipitation, co-localization assays, CNS tissue co-staining","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 3 + moderate — Y2H discovery validated by co-IP and co-localization in multiple systems","pmids":["23142642"],"is_preprint":false},{"year":2018,"finding":"CLN8 functions as an ER cargo receptor for lysosomal enzymes, mediating their ER-to-Golgi transfer via interaction with the COPII (export) and COPI (retrieval) machineries through specific signals in its cytosolic C-terminus; the second luminal loop of CLN8 binds lysosomal enzymes and is required for this interaction; CLN8 deficiency depletes soluble enzymes from lysosomes, impairing lysosome biogenesis; disease-causing mutations in the second luminal loop abolish enzyme binding.","method":"Co-immunoprecipitation, trafficking assays, mutagenesis of export/retrieval signals and luminal loop, CLN8 knockout/knockdown with lysosomal enzyme quantification","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including mutagenesis, co-IP, trafficking assays, KO with defined mechanistic readout; strong evidence","pmids":["30397314"],"is_preprint":false},{"year":2018,"finding":"CLN8 interacts with PP2A and its inhibitor I2PP2A; CLN8 deficiency leads to increased PP2A phosphatase activity (reduced phosphorylation of Akt, S6 kinase, GSK3β substrates) in patient fibroblasts; ceramide levels are reduced by ~60% in CLN8-deficient cells; transport of ceramide from ER to Golgi is not affected by CLN8 deficiency.","method":"Co-immunoprecipitation of CLN8 with PP2A/I2PP2A, phospho-western blotting, pharmacological rescue with cantharidin, NBD-ceramide trafficking assay, lipidomics","journal":"Biochimica et biophysica acta. Molecular basis of disease","confidence":"Medium","confidence_rationale":"Tier 2-3 — co-IP with functional phospho-substrate readout and lipid transport assay, single lab","pmids":["30453012"],"is_preprint":false},{"year":2020,"finding":"CLN6 forms an obligate complex with CLN8 (termed EGRESS: ER-to-Golgi relaying of enzymes of the lysosomal system) that recruits lysosomal enzymes at the ER for Golgi transfer; the second luminal loop of CLN6 is required for binding lysosomal enzymes but not for interaction with CLN8; CLN6 deficiency reduces ER export of lysosomal enzymes; mice lacking both CLN6 and CLN8 show no aggravated pathology compared to single knockouts, confirming both proteins act in the same functional unit.","method":"Co-immunoprecipitation, mutagenesis of CLN6 luminal loop, trafficking assays, lysosomal enzyme quantification, CLN6/CLN8 double-knockout mice with epistasis analysis","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1-2 — reciprocal co-IP, mutagenesis, in vivo epistasis (double KO), multiple orthogonal methods across in vitro and in vivo systems","pmids":["32597833"],"is_preprint":false},{"year":2021,"finding":"CLN8 knockdown increases Golgi apparatus size, increases number and speed of mobile endo-lysosomes, causes lysosomal alkalisation, and reduces complexity/size of the somatodendritic compartment in primary rat hippocampal neurons.","method":"CLN8 siRNA knockdown, live-cell fluorescence imaging of endo-lysosomes (mApple-LAMP1-pHluorin), confocal microscopy of Golgi, dendritic morphometry in primary neurons","journal":"Biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 — KD with multiple defined cellular phenotypes using live imaging, single lab","pmids":["34021618"],"is_preprint":false},{"year":2024,"finding":"CLN8 dysfunction impairs autophagy; treatment with autophagy modulators trehalose and SG2 attenuates the pathological phenotype in CLN8-deficient zebrafish larvae.","method":"CLN8-deficient zebrafish model (loss-of-function), autophagy pathway analysis, pharmacological rescue with trehalose and SG2","journal":"Neurobiology of disease","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo zebrafish KO with pharmacological rescue supporting autophagy pathway placement","pmids":["38763444"],"is_preprint":false},{"year":2025,"finding":"CLN8 is a lysophosphatidylglycerol acyltransferase that catalyzes an essential step in the biosynthesis of bis(monoacylglycero)phosphate (BMP), a phospholipid critical for lysosome function; this enzymatic activity is demonstrated for the human CLN8 protein.","method":"In vitro acyltransferase assay, lipidomics, biochemical reconstitution","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1 — direct enzymatic assay demonstrating acyltransferase activity with identification of specific substrate and product","pmids":["39970228"],"is_preprint":false}],"current_model":"CLN8 is an ER-resident transmembrane lysophosphatidylglycerol acyltransferase that catalyzes a critical step in bis(monoacylglycero)phosphate biosynthesis for lysosome function, acts as an ER cargo receptor forming the EGRESS complex with CLN6 to recruit lysosomal enzymes at the ER and mediate their COPII/COPI-dependent ER-to-Golgi transfer, and interacts with PP2A/I2PP2A to regulate ceramide levels and downstream signaling; loss of CLN8 depletes lysosomal enzymes, impairs lysosome biogenesis and autophagy, disrupts mitochondrial Ca2+ buffering, and causes the neurodegenerative lysosomal storage disorder neuronal ceroid lipofuscinosis (Batten disease)."},"narrative":{"teleology":[{"year":1999,"claim":"Positional cloning identified CLN8 as a novel transmembrane protein whose mutations cause progressive epilepsy with mental retardation (EPMR) in humans and motor neuron degeneration in mnd mice, establishing CLN8 as a neuronal ceroid lipofuscinosis gene.","evidence":"Positional cloning and mutation screening in human EPMR families and mnd mice","pmids":["10508524"],"confidence":"High","gaps":["Protein function entirely unknown at this stage","Subcellular localization not determined","No mechanistic connection to lipofuscin storage"]},{"year":2000,"claim":"Determination that CLN8 is an ER-resident protein recycling through the ERGIC via a C-terminal KKRP retrieval signal established the ER as its primary site of action and suggested involvement in ER-to-Golgi trafficking.","evidence":"Confocal immunofluorescence, pulse-chase, site-directed mutagenesis of KKRP motif","pmids":["10861296"],"confidence":"High","gaps":["Cargo being trafficked unknown","Enzymatic activity not addressed","Neuronal localization not yet confirmed"]},{"year":2004,"claim":"Confirmation of ER localization in primary hippocampal neurons, and the finding that disease mutations do not mislocalize CLN8, indicated that pathogenesis arises from loss of CLN8 function rather than mislocalization.","evidence":"Viral expression in primary neurons, subcellular fractionation of mouse brain","pmids":["15160397"],"confidence":"Medium","gaps":["Functional activity of CLN8 at the ER still unknown","Brain fractionation placed endogenous Cln8 in non-ER light membranes, suggesting additional compartments"]},{"year":2011,"claim":"Two parallel discoveries linked CLN8 to ceramide metabolism and to mitochondrial calcium handling: CLN8-deficient cells showed reduced ceramide synthase activity and decreased ceramide species, while Cln8mnd neurons exhibited impaired mitochondrial Ca²⁺ uptake, revealing downstream consequences of CLN8 loss.","evidence":"Mass spectrometry lipidomics and co-IP with ceramide synthase; patch-clamp and Ca²⁺ imaging in Cln8mnd hippocampal neurons","pmids":["23160995","21917311"],"confidence":"Medium","gaps":["Whether CLN8 directly catalyzes ceramide synthesis or acts indirectly was unclear","Relationship between ceramide deficiency and mitochondrial Ca²⁺ defect not established","Single-lab findings for each"]},{"year":2012,"claim":"Identification of CLN8 physical interactors including VAPA, GATE16/GABARAPL2, and BNIP3/BNIP3L expanded the functional network to ER–organelle contacts and autophagy-related pathways.","evidence":"Split-ubiquitin membrane yeast two-hybrid screen validated by co-IP and co-localization in mammalian cells and CNS tissue","pmids":["23142642"],"confidence":"Medium","gaps":["Functional significance of VAPA and GATE16 interactions not tested by loss-of-function","Y2H-derived interactions require further in vivo validation","No direct link to lysosomal enzyme trafficking yet"]},{"year":2018,"claim":"A breakthrough study revealed CLN8 functions as an ER cargo receptor for lysosomal enzymes, with its second luminal loop directly binding enzymes and its cytosolic C-terminus engaging COPII/COPI machinery; this explained how CLN8 loss depletes lysosomes of soluble enzymes and impairs lysosome biogenesis.","evidence":"Co-IP, mutagenesis of export/retrieval signals and luminal loop, CLN8 KO/KD with lysosomal enzyme quantification and trafficking assays","pmids":["30397314"],"confidence":"High","gaps":["Whether CLN8 acts alone or requires a co-receptor was unknown","Enzymatic activity of CLN8 itself not addressed","Selectivity mechanism for different lysosomal enzymes not defined"]},{"year":2018,"claim":"The discovery that CLN8 interacts with PP2A and its inhibitor I2PP2A, with CLN8 deficiency increasing PP2A activity and reducing Akt/S6K/GSK3β phosphorylation, provided a signaling axis linking CLN8 to cell survival regulation independent of its cargo receptor role.","evidence":"Co-IP of CLN8–PP2A/I2PP2A, phospho-western blotting, pharmacological rescue with cantharidin in patient fibroblasts","pmids":["30453012"],"confidence":"Medium","gaps":["Relationship between PP2A regulation and lysosomal enzyme trafficking not clarified","Single-lab observation","Whether PP2A interaction is direct or bridged through a common complex unclear"]},{"year":2020,"claim":"Demonstration that CLN6 and CLN8 form an obligate complex (EGRESS) that jointly recruits lysosomal enzymes at the ER resolved how ER cargo reception is organized; epistasis analysis in double-KO mice confirmed they act in the same pathway.","evidence":"Reciprocal co-IP, CLN6 luminal loop mutagenesis, trafficking assays, CLN6/CLN8 double-knockout mice","pmids":["32597833"],"confidence":"High","gaps":["Stoichiometry and structure of the EGRESS complex unknown","How EGRESS distinguishes different lysosomal enzymes from other ER cargo not defined","Whether additional ER factors participate in the complex"]},{"year":2021,"claim":"CLN8 knockdown in primary neurons caused Golgi expansion, altered endo-lysosome dynamics, lysosomal alkalinization, and dendritic atrophy, providing a cellular phenotype linking CLN8 loss to neuronal morphology defects.","evidence":"siRNA knockdown with live-cell LAMP1-pHluorin imaging and dendritic morphometry in rat hippocampal neurons","pmids":["34021618"],"confidence":"Medium","gaps":["Whether Golgi expansion is a direct consequence of impaired ER-to-Golgi trafficking or secondary","No rescue experiment reported","Mechanism of dendritic simplification not established"]},{"year":2024,"claim":"CLN8 dysfunction was shown to impair autophagy in vivo, and pharmacological enhancement of autophagy with trehalose/SG2 attenuated pathology in CLN8-deficient zebrafish, establishing autophagy as a therapeutically relevant downstream pathway.","evidence":"CLN8 loss-of-function zebrafish model with autophagy analysis and pharmacological rescue","pmids":["38763444"],"confidence":"Medium","gaps":["Molecular step at which autophagy is blocked not defined","Whether autophagy impairment is secondary to lysosomal enzyme depletion or an independent function of CLN8","Relevance to mammalian disease models not yet tested"]},{"year":2025,"claim":"Biochemical reconstitution demonstrated that CLN8 is a lysophosphatidylglycerol acyltransferase catalyzing a critical step in BMP biosynthesis, revealing for the first time a direct enzymatic activity for CLN8 and explaining its requirement for lysosome membrane lipid homeostasis.","evidence":"In vitro acyltransferase assay with substrate/product identification by lipidomics","pmids":["39970228"],"confidence":"High","gaps":["How acyltransferase activity is coordinated with the EGRESS cargo receptor function is unknown","Structural basis of dual function not resolved","Whether BMP deficiency or enzyme depletion is the primary driver of NCL pathology remains open"]},{"year":null,"claim":"It remains unknown how CLN8 integrates its dual roles as an acyltransferase for BMP biosynthesis and as an ER cargo receptor within the EGRESS complex, whether these functions are separable, and which activity is the primary driver of neurodegeneration in NCL.","evidence":"","pmids":[],"confidence":"High","gaps":["No structure of CLN8 or the EGRESS complex","Relative contribution of BMP deficiency vs. lysosomal enzyme depletion to disease not dissected","Cell-type-specific functions in neurons vs. glia not resolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[13]},{"term_id":"GO:0038024","term_label":"cargo receptor activity","supporting_discovery_ids":[8,10]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[1,3,8]}],"pathway":[{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[12]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[8,10]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[5,13]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[8,10,11]}],"complexes":["EGRESS complex (CLN6-CLN8)"],"partners":["CLN6","VAPA","GABARAPL2","PP2A","I2PP2A","BNIP3L","STX8"],"other_free_text":[]},"mechanistic_narrative":"CLN8 is an ER-resident transmembrane protein that serves dual roles as a lysophosphatidylglycerol acyltransferase essential for bis(monoacylglycero)phosphate (BMP) biosynthesis and as an ER cargo receptor for lysosomal enzymes, thereby governing lysosome biogenesis and function [PMID:39970228, PMID:30397314]. CLN8 forms the EGRESS complex with CLN6, which recruits soluble lysosomal enzymes at the ER via its second luminal loop and mediates their COPII/COPI-dependent export to the Golgi; disease-causing mutations in this loop abolish enzyme binding and deplete lysosomal enzymes [PMID:30397314, PMID:32597833]. CLN8 also interacts with PP2A/I2PP2A to regulate ceramide levels and downstream Akt/S6K/GSK3β signaling, and its loss impairs mitochondrial calcium buffering, autophagy, and neuronal viability [PMID:30453012, PMID:21917311, PMID:38763444]. Loss-of-function mutations in CLN8 cause neuronal ceroid lipofuscinosis (Batten disease), a neurodegenerative lysosomal storage disorder [PMID:10508524]."},"prefetch_data":{"uniprot":{"accession":"Q9UBY8","full_name":"Protein CLN8","aliases":[],"length_aa":286,"mass_kda":32.8,"function":"Could play a role in cell proliferation during neuronal differentiation and in protection against cell death","subcellular_location":"Endoplasmic reticulum membrane; Endoplasmic reticulum-Golgi intermediate compartment membrane; Endoplasmic reticulum","url":"https://www.uniprot.org/uniprotkb/Q9UBY8/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CLN8","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CLN8","total_profiled":1310},"omim":[{"mim_id":"620967","title":"TLC DOMAIN-CONTAINING PROTEIN 2; TLCD2","url":"https://www.omim.org/entry/620967"},{"mim_id":"620966","title":"TLC DOMAIN-CONTAINING PROTEIN 1; TLCD1","url":"https://www.omim.org/entry/620966"},{"mim_id":"615336","title":"CERAMIDE SYNTHASE 6; CERS6","url":"https://www.omim.org/entry/615336"},{"mim_id":"615335","title":"CERAMIDE SYNTHASE 5; CERS5","url":"https://www.omim.org/entry/615335"},{"mim_id":"615334","title":"CERAMIDE SYNTHASE 4; CERS4","url":"https://www.omim.org/entry/615334"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CLN8"},"hgnc":{"alias_symbol":["FLJ39417","TLCD6"],"prev_symbol":["EPMR","C8orf61"]},"alphafold":{"accession":"Q9UBY8","domains":[{"cath_id":"-","chopping":"20-257","consensus_level":"high","plddt":96.8556,"start":20,"end":257}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UBY8","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UBY8-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UBY8-F1-predicted_aligned_error_v6.png","plddt_mean":90.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CLN8","jax_strain_url":"https://www.jax.org/strain/search?query=CLN8"},"sequence":{"accession":"Q9UBY8","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UBY8.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UBY8/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UBY8"}},"corpus_meta":[{"pmid":"10508524","id":"PMC_10508524","title":"The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8.","date":"1999","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10508524","citation_count":234,"is_preprint":false},{"pmid":"12151215","id":"PMC_12151215","title":"TRAM, LAG1 and CLN8: members of a novel family of lipid-sensing domains?","date":"2002","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/12151215","citation_count":136,"is_preprint":false},{"pmid":"15629147","id":"PMC_15629147","title":"A mutation in the CLN8 gene in English Setter dogs with neuronal ceroid-lipofuscinosis.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15629147","citation_count":102,"is_preprint":false},{"pmid":"10861296","id":"PMC_10861296","title":"The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum.","date":"2000","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10861296","citation_count":91,"is_preprint":false},{"pmid":"30397314","id":"PMC_30397314","title":"CLN8 is an endoplasmic reticulum cargo receptor that regulates lysosome biogenesis.","date":"2018","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30397314","citation_count":86,"is_preprint":false},{"pmid":"32597833","id":"PMC_32597833","title":"A CLN6-CLN8 complex recruits lysosomal enzymes at the ER for Golgi transfer.","date":"2020","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/32597833","citation_count":68,"is_preprint":false},{"pmid":"22144673","id":"PMC_22144673","title":"Acyl chain specificity of ceramide synthases is determined within a region of 150 residues in the Tram-Lag-CLN8 (TLC) domain.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22144673","citation_count":55,"is_preprint":false},{"pmid":"16086686","id":"PMC_16086686","title":"Mass spectrometric analysis reveals changes in phospholipid, neutral sphingolipid and sulfatide molecular species in progressive epilepsy with mental retardation, EPMR, brain: a case study.","date":"2005","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16086686","citation_count":53,"is_preprint":false},{"pmid":"22388998","id":"PMC_22388998","title":"Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation.","date":"2012","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/22388998","citation_count":48,"is_preprint":false},{"pmid":"19431184","id":"PMC_19431184","title":"A novel CLN8 mutation in late-infantile-onset neuronal ceroid lipofuscinosis (LINCL) reveals aspects of CLN8 neurobiological function.","date":"2009","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/19431184","citation_count":45,"is_preprint":false},{"pmid":"23160995","id":"PMC_23160995","title":"CLN5 and CLN8 protein association with ceramide synthase: biochemical and proteomic approaches.","date":"2012","source":"Electrophoresis","url":"https://pubmed.ncbi.nlm.nih.gov/23160995","citation_count":45,"is_preprint":false},{"pmid":"24953404","id":"PMC_24953404","title":"A CLN8 nonsense mutation in the whole genome sequence of a mixed breed dog with neuronal ceroid lipofuscinosis and Australian Shepherd ancestry.","date":"2014","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24953404","citation_count":41,"is_preprint":false},{"pmid":"16570191","id":"PMC_16570191","title":"Novel mutations in CLN8 in Italian variant late infantile neuronal ceroid lipofuscinosis: Another genetic hit in the Mediterranean.","date":"2006","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/16570191","citation_count":38,"is_preprint":false},{"pmid":"15160397","id":"PMC_15160397","title":"Localization of wild-type and mutant neuronal ceroid lipofuscinosis CLN8 proteins in non-neuronal and neuronal cells.","date":"2004","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/15160397","citation_count":35,"is_preprint":false},{"pmid":"33010819","id":"PMC_33010819","title":"AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten Disease.","date":"2020","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33010819","citation_count":35,"is_preprint":false},{"pmid":"11589000","id":"PMC_11589000","title":"Turkish variant late infantile neuronal ceroid lipofuscinosis (CLN7) may be allelic to CLN8.","date":"2001","source":"European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society","url":"https://pubmed.ncbi.nlm.nih.gov/11589000","citation_count":34,"is_preprint":false},{"pmid":"23142642","id":"PMC_23142642","title":"Identifying protein partners of CLN8, an ER-resident protein involved in neuronal ceroid lipofuscinosis.","date":"2012","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/23142642","citation_count":30,"is_preprint":false},{"pmid":"21094208","id":"PMC_21094208","title":"Different early ER-stress responses in the CLN8(mnd) mouse model of neuronal ceroid lipofuscinosis.","date":"2010","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/21094208","citation_count":27,"is_preprint":false},{"pmid":"19807737","id":"PMC_19807737","title":"Novel CLN8 mutations confirm the clinical and ethnic diversity of late infantile neuronal ceroid lipofuscinosis.","date":"2009","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19807737","citation_count":27,"is_preprint":false},{"pmid":"28024876","id":"PMC_28024876","title":"Neuronal ceroid lipofuscinosis (NCL) is caused by the entire deletion of CLN8 in the Alpenländische Dachsbracke dog.","date":"2016","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/28024876","citation_count":24,"is_preprint":false},{"pmid":"17560505","id":"PMC_17560505","title":"A novel mutation of the CLN8 gene: is there a Mediterranean phenotype?","date":"2007","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/17560505","citation_count":20,"is_preprint":false},{"pmid":"21917311","id":"PMC_21917311","title":"Deficient mitochondrial Ca(2+) buffering in the Cln8(mnd) mouse model of neuronal ceroid lipofuscinosis.","date":"2011","source":"Cell calcium","url":"https://pubmed.ncbi.nlm.nih.gov/21917311","citation_count":20,"is_preprint":false},{"pmid":"29446145","id":"PMC_29446145","title":"Neuronal ceroid lipofuscinosis in Salukis is caused by a single base pair insertion in CLN8.","date":"2018","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29446145","citation_count":16,"is_preprint":false},{"pmid":"11332769","id":"PMC_11332769","title":"Studies of homogenous populations: CLN5 and CLN8.","date":"2001","source":"Advances in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11332769","citation_count":15,"is_preprint":false},{"pmid":"30453012","id":"PMC_30453012","title":"Neuronal ceroid lipofuscinosis related ER membrane protein CLN8 regulates PP2A activity and ceramide levels.","date":"2018","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/30453012","citation_count":13,"is_preprint":false},{"pmid":"8743986","id":"PMC_8743986","title":"Genetic and physical mapping of the progressive epilepsy with mental retardation (EPMR) locus on chromosome 8p.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8743986","citation_count":13,"is_preprint":false},{"pmid":"31687336","id":"PMC_31687336","title":"Neuronal ceroid lipofuscinosis in a German Shorthaired Pointer associated with a previously reported CLN8 nonsense variant.","date":"2019","source":"Molecular genetics and metabolism reports","url":"https://pubmed.ncbi.nlm.nih.gov/31687336","citation_count":13,"is_preprint":false},{"pmid":"34021618","id":"PMC_34021618","title":"The neuronal ceroid lipofuscinosis-related protein CLN8 regulates endo-lysosomal dynamics and dendritic morphology.","date":"2021","source":"Biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/34021618","citation_count":12,"is_preprint":false},{"pmid":"34044364","id":"PMC_34044364","title":"miR-3074-5p/CLN8 pathway regulates decidualization in recurrent miscarriage.","date":"2021","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/34044364","citation_count":12,"is_preprint":false},{"pmid":"22964447","id":"PMC_22964447","title":"Phenotypic heterogeneity in consanguineous patients with a common CLN8 mutation.","date":"2012","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/22964447","citation_count":11,"is_preprint":false},{"pmid":"28116333","id":"PMC_28116333","title":"CLN8 disease caused by large genomic deletions.","date":"2016","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28116333","citation_count":8,"is_preprint":false},{"pmid":"37121996","id":"PMC_37121996","title":"A novel candidate gene CLN8 regulates fat deposition in avian.","date":"2023","source":"Journal of animal science and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/37121996","citation_count":7,"is_preprint":false},{"pmid":"38763444","id":"PMC_38763444","title":"Targeting autophagy impairment improves the phenotype of a novel CLN8 zebrafish model.","date":"2024","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/38763444","citation_count":7,"is_preprint":false},{"pmid":"11588991","id":"PMC_11588991","title":"Northern epilepsy syndrome (NES, CLN8)--MRI and electrophysiological studies.","date":"2001","source":"European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society","url":"https://pubmed.ncbi.nlm.nih.gov/11588991","citation_count":7,"is_preprint":false},{"pmid":"34201538","id":"PMC_34201538","title":"CLN8 Mutations Presenting with a Phenotypic Continuum of Neuronal Ceroid Lipofuscinosis-Literature Review and Case Report.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/34201538","citation_count":7,"is_preprint":false},{"pmid":"26443629","id":"PMC_26443629","title":"Novel missense mutation in CLN8 in late infantile neuronal ceroid lipofuscinosis: The first report of a CLN8 mutation in Japan.","date":"2015","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/26443629","citation_count":7,"is_preprint":false},{"pmid":"30741402","id":"PMC_30741402","title":"Congenital CLN8 disease of neuronal ceroid lipofuscinosis: a novel phenotype.","date":"2019","source":"Revista de neurologia","url":"https://pubmed.ncbi.nlm.nih.gov/30741402","citation_count":7,"is_preprint":false},{"pmid":"27844444","id":"PMC_27844444","title":"Exome sequencing identifies a novel homozygous CLN8 mutation in a Turkish family with Northern epilepsy.","date":"2016","source":"Acta neurologica Belgica","url":"https://pubmed.ncbi.nlm.nih.gov/27844444","citation_count":6,"is_preprint":false},{"pmid":"33358637","id":"PMC_33358637","title":"Status dystonicus associated with CLN8 disease.","date":"2020","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/33358637","citation_count":5,"is_preprint":false},{"pmid":"30919163","id":"PMC_30919163","title":"The Neuronal Ceroid Lipofuscinoses-Linked Loss of Function CLN5 and CLN8 Variants Disrupt Normal Lysosomal Function.","date":"2019","source":"Neuromolecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30919163","citation_count":4,"is_preprint":false},{"pmid":"36369162","id":"PMC_36369162","title":"Sex-split analysis of pathology and motor-behavioral outcomes in a mouse model of CLN8-Batten disease reveals an increased disease burden and trajectory in female Cln8mnd mice.","date":"2022","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/36369162","citation_count":4,"is_preprint":false},{"pmid":"39970228","id":"PMC_39970228","title":"TRAM-LAG1-CLN8 family proteins are acyltransferases regulating phospholipid composition.","date":"2025","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/39970228","citation_count":3,"is_preprint":false},{"pmid":"36011304","id":"PMC_36011304","title":"CLN8 Gene Compound Heterozygous Variants: A New Case and Protein Bioinformatics Analyses.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/36011304","citation_count":3,"is_preprint":false},{"pmid":"38751748","id":"PMC_38751748","title":"Two compound heterozygous variants in the CLN8 gene are responsible for neuronal cereidolipofuscinoses disorder in a child: a case report.","date":"2024","source":"Frontiers in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/38751748","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.08.10.25333392","title":"Identification and Validation of a Lipid Metabolism-associated Gene Signature for Predicting Survival in Sepsis Patients","date":"2025-08-12","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.10.25333392","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":23368,"output_tokens":3379,"usd":0.060394},"stage2":{"model":"claude-opus-4-6","input_tokens":6768,"output_tokens":5987,"usd":0.275272},"total_usd":0.335666,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"CLN8 encodes a novel putative transmembrane protein of 286 amino acids; a missense mutation (R24G) in human EPMR patients and a 1-bp insertion causing frameshift/truncation in mnd mice were identified as disease-causing mutations in orthologous CLN8 genes.\",\n      \"method\": \"Positional cloning, sequence analysis, mutation screening\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — positional cloning with mutation identification in both human and mouse orthologs, foundational paper with 234 citations\",\n      \"pmids\": [\"10508524\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CLN8 protein is an ER-resident transmembrane protein (~33 kDa) that recycles between the ER and ER-Golgi intermediate compartment (ERGIC); the C-terminal KKRP motif functions as an ER retrieval signal, and mutation of this signal redirects CLN8 to the Golgi apparatus.\",\n      \"method\": \"Western blotting, pulse-chase analysis, confocal immunofluorescence microscopy with organelle-specific antibodies, site-directed mutagenesis of KKRP signal\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including mutagenesis of retrieval signal with functional localization readout\",\n      \"pmids\": [\"10861296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"CLN8 is identified as a member of the TLC (TRAM-LAG1-CLN8) domain family, related to yeast Lag1p and mammalian TRAM, implicating the protein in ceramide synthesis, lipid regulation, or protein translocation at the ER.\",\n      \"method\": \"Bioinformatic sequence analysis and domain family identification\",\n      \"journal\": \"Trends in biochemical sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — computational/bioinformatic prediction only\",\n      \"pmids\": [\"12151215\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CLN8 localizes to the ER in mouse hippocampal primary neurons; CLN8 shows basolateral targeting in polarized epithelial CaCo-2 cells; endogenous mouse Cln8 is found in light membrane fractions distinct from ER in brain fractionation; disease mutations do not alter intracellular localization of CLN8 in neuronal or non-neuronal cells.\",\n      \"method\": \"Semliki Forest virus-mediated expression, immunofluorescence microscopy with subcellular markers, subcellular fractionation of mouse brain tissue\",\n      \"journal\": \"Journal of neuroscience research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization in neurons with fractionation, but single lab\",\n      \"pmids\": [\"15160397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CLN8 plays a role in cell proliferation during neuronal differentiation and in protection against cell death; expression of patient-mutation CLN8 proteins in neuronal cell models and gene silencing both impaired proliferation and increased cell death during neuronal differentiation.\",\n      \"method\": \"Overexpression of wild-type and mutant CLN8 in neuronal cell models, siRNA gene silencing, cell proliferation and cell death assays\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD/OE with defined cellular phenotype validated by two complementary approaches\",\n      \"pmids\": [\"19431184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CLN8-deficient (CLN8−/−) cells have decreased ceramide synthase activity and reduced C16/C18:0/C24:0/C24:1 ceramide species; CLN8 protein functionally complements CLN5-deficient cells, correcting growth and apoptosis defects; CLN8 protein was found to interact with ceramide synthase complex.\",\n      \"method\": \"Mass spectrometry-based ceramide species quantification, co-immunoprecipitation, complementation assays in CLN5-deficient fibroblasts\",\n      \"journal\": \"Electrophoresis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — co-IP and functional complementation with MS quantification, single lab\",\n      \"pmids\": [\"23160995\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In Cln8mnd hippocampal neurons, clearance of large Ca2+ loads is inefficient due to impaired mitochondrial Ca2+ uptake; neither SERCA-mediated ER Ca2+ uptake nor plasma membrane Ca2+ extrusion is affected by the Cln8 mutation.\",\n      \"method\": \"Patch clamp electrophysiology, fluorescence Ca2+ imaging, caged Ca2+ photolysis in hippocampal slices and cultured neurons\",\n      \"journal\": \"Cell calcium\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple electrophysiological and imaging methods in Cln8mnd mouse neurons with specific mechanistic dissection\",\n      \"pmids\": [\"21917311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CLN8 protein interacts with VAPA, c14orf1/hERG28, STX8, GATE16, BNIP3, and BNIP3L; interactions with VAPA and GATE16 were validated by co-immunoprecipitation and co-localization assays in mammalian cells and confirmed in CNS tissues.\",\n      \"method\": \"Split-ubiquitin membrane yeast two-hybrid (MYTH) screen with human brain cDNA library, co-immunoprecipitation, co-localization assays, CNS tissue co-staining\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 + moderate — Y2H discovery validated by co-IP and co-localization in multiple systems\",\n      \"pmids\": [\"23142642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CLN8 functions as an ER cargo receptor for lysosomal enzymes, mediating their ER-to-Golgi transfer via interaction with the COPII (export) and COPI (retrieval) machineries through specific signals in its cytosolic C-terminus; the second luminal loop of CLN8 binds lysosomal enzymes and is required for this interaction; CLN8 deficiency depletes soluble enzymes from lysosomes, impairing lysosome biogenesis; disease-causing mutations in the second luminal loop abolish enzyme binding.\",\n      \"method\": \"Co-immunoprecipitation, trafficking assays, mutagenesis of export/retrieval signals and luminal loop, CLN8 knockout/knockdown with lysosomal enzyme quantification\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including mutagenesis, co-IP, trafficking assays, KO with defined mechanistic readout; strong evidence\",\n      \"pmids\": [\"30397314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CLN8 interacts with PP2A and its inhibitor I2PP2A; CLN8 deficiency leads to increased PP2A phosphatase activity (reduced phosphorylation of Akt, S6 kinase, GSK3β substrates) in patient fibroblasts; ceramide levels are reduced by ~60% in CLN8-deficient cells; transport of ceramide from ER to Golgi is not affected by CLN8 deficiency.\",\n      \"method\": \"Co-immunoprecipitation of CLN8 with PP2A/I2PP2A, phospho-western blotting, pharmacological rescue with cantharidin, NBD-ceramide trafficking assay, lipidomics\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular basis of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — co-IP with functional phospho-substrate readout and lipid transport assay, single lab\",\n      \"pmids\": [\"30453012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"CLN6 forms an obligate complex with CLN8 (termed EGRESS: ER-to-Golgi relaying of enzymes of the lysosomal system) that recruits lysosomal enzymes at the ER for Golgi transfer; the second luminal loop of CLN6 is required for binding lysosomal enzymes but not for interaction with CLN8; CLN6 deficiency reduces ER export of lysosomal enzymes; mice lacking both CLN6 and CLN8 show no aggravated pathology compared to single knockouts, confirming both proteins act in the same functional unit.\",\n      \"method\": \"Co-immunoprecipitation, mutagenesis of CLN6 luminal loop, trafficking assays, lysosomal enzyme quantification, CLN6/CLN8 double-knockout mice with epistasis analysis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reciprocal co-IP, mutagenesis, in vivo epistasis (double KO), multiple orthogonal methods across in vitro and in vivo systems\",\n      \"pmids\": [\"32597833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CLN8 knockdown increases Golgi apparatus size, increases number and speed of mobile endo-lysosomes, causes lysosomal alkalisation, and reduces complexity/size of the somatodendritic compartment in primary rat hippocampal neurons.\",\n      \"method\": \"CLN8 siRNA knockdown, live-cell fluorescence imaging of endo-lysosomes (mApple-LAMP1-pHluorin), confocal microscopy of Golgi, dendritic morphometry in primary neurons\",\n      \"journal\": \"Biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD with multiple defined cellular phenotypes using live imaging, single lab\",\n      \"pmids\": [\"34021618\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CLN8 dysfunction impairs autophagy; treatment with autophagy modulators trehalose and SG2 attenuates the pathological phenotype in CLN8-deficient zebrafish larvae.\",\n      \"method\": \"CLN8-deficient zebrafish model (loss-of-function), autophagy pathway analysis, pharmacological rescue with trehalose and SG2\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo zebrafish KO with pharmacological rescue supporting autophagy pathway placement\",\n      \"pmids\": [\"38763444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CLN8 is a lysophosphatidylglycerol acyltransferase that catalyzes an essential step in the biosynthesis of bis(monoacylglycero)phosphate (BMP), a phospholipid critical for lysosome function; this enzymatic activity is demonstrated for the human CLN8 protein.\",\n      \"method\": \"In vitro acyltransferase assay, lipidomics, biochemical reconstitution\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct enzymatic assay demonstrating acyltransferase activity with identification of specific substrate and product\",\n      \"pmids\": [\"39970228\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CLN8 is an ER-resident transmembrane lysophosphatidylglycerol acyltransferase that catalyzes a critical step in bis(monoacylglycero)phosphate biosynthesis for lysosome function, acts as an ER cargo receptor forming the EGRESS complex with CLN6 to recruit lysosomal enzymes at the ER and mediate their COPII/COPI-dependent ER-to-Golgi transfer, and interacts with PP2A/I2PP2A to regulate ceramide levels and downstream signaling; loss of CLN8 depletes lysosomal enzymes, impairs lysosome biogenesis and autophagy, disrupts mitochondrial Ca2+ buffering, and causes the neurodegenerative lysosomal storage disorder neuronal ceroid lipofuscinosis (Batten disease).\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CLN8 is an ER-resident transmembrane protein that serves dual roles as a lysophosphatidylglycerol acyltransferase essential for bis(monoacylglycero)phosphate (BMP) biosynthesis and as an ER cargo receptor for lysosomal enzymes, thereby governing lysosome biogenesis and function [PMID:39970228, PMID:30397314]. CLN8 forms the EGRESS complex with CLN6, which recruits soluble lysosomal enzymes at the ER via its second luminal loop and mediates their COPII/COPI-dependent export to the Golgi; disease-causing mutations in this loop abolish enzyme binding and deplete lysosomal enzymes [PMID:30397314, PMID:32597833]. CLN8 also interacts with PP2A/I2PP2A to regulate ceramide levels and downstream Akt/S6K/GSK3β signaling, and its loss impairs mitochondrial calcium buffering, autophagy, and neuronal viability [PMID:30453012, PMID:21917311, PMID:38763444]. Loss-of-function mutations in CLN8 cause neuronal ceroid lipofuscinosis (Batten disease), a neurodegenerative lysosomal storage disorder [PMID:10508524].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Positional cloning identified CLN8 as a novel transmembrane protein whose mutations cause progressive epilepsy with mental retardation (EPMR) in humans and motor neuron degeneration in mnd mice, establishing CLN8 as a neuronal ceroid lipofuscinosis gene.\",\n      \"evidence\": \"Positional cloning and mutation screening in human EPMR families and mnd mice\",\n      \"pmids\": [\"10508524\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Protein function entirely unknown at this stage\", \"Subcellular localization not determined\", \"No mechanistic connection to lipofuscin storage\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Determination that CLN8 is an ER-resident protein recycling through the ERGIC via a C-terminal KKRP retrieval signal established the ER as its primary site of action and suggested involvement in ER-to-Golgi trafficking.\",\n      \"evidence\": \"Confocal immunofluorescence, pulse-chase, site-directed mutagenesis of KKRP motif\",\n      \"pmids\": [\"10861296\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cargo being trafficked unknown\", \"Enzymatic activity not addressed\", \"Neuronal localization not yet confirmed\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Confirmation of ER localization in primary hippocampal neurons, and the finding that disease mutations do not mislocalize CLN8, indicated that pathogenesis arises from loss of CLN8 function rather than mislocalization.\",\n      \"evidence\": \"Viral expression in primary neurons, subcellular fractionation of mouse brain\",\n      \"pmids\": [\"15160397\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional activity of CLN8 at the ER still unknown\", \"Brain fractionation placed endogenous Cln8 in non-ER light membranes, suggesting additional compartments\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Two parallel discoveries linked CLN8 to ceramide metabolism and to mitochondrial calcium handling: CLN8-deficient cells showed reduced ceramide synthase activity and decreased ceramide species, while Cln8mnd neurons exhibited impaired mitochondrial Ca²⁺ uptake, revealing downstream consequences of CLN8 loss.\",\n      \"evidence\": \"Mass spectrometry lipidomics and co-IP with ceramide synthase; patch-clamp and Ca²⁺ imaging in Cln8mnd hippocampal neurons\",\n      \"pmids\": [\"23160995\", \"21917311\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether CLN8 directly catalyzes ceramide synthesis or acts indirectly was unclear\", \"Relationship between ceramide deficiency and mitochondrial Ca²⁺ defect not established\", \"Single-lab findings for each\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identification of CLN8 physical interactors including VAPA, GATE16/GABARAPL2, and BNIP3/BNIP3L expanded the functional network to ER–organelle contacts and autophagy-related pathways.\",\n      \"evidence\": \"Split-ubiquitin membrane yeast two-hybrid screen validated by co-IP and co-localization in mammalian cells and CNS tissue\",\n      \"pmids\": [\"23142642\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional significance of VAPA and GATE16 interactions not tested by loss-of-function\", \"Y2H-derived interactions require further in vivo validation\", \"No direct link to lysosomal enzyme trafficking yet\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"A breakthrough study revealed CLN8 functions as an ER cargo receptor for lysosomal enzymes, with its second luminal loop directly binding enzymes and its cytosolic C-terminus engaging COPII/COPI machinery; this explained how CLN8 loss depletes lysosomes of soluble enzymes and impairs lysosome biogenesis.\",\n      \"evidence\": \"Co-IP, mutagenesis of export/retrieval signals and luminal loop, CLN8 KO/KD with lysosomal enzyme quantification and trafficking assays\",\n      \"pmids\": [\"30397314\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CLN8 acts alone or requires a co-receptor was unknown\", \"Enzymatic activity of CLN8 itself not addressed\", \"Selectivity mechanism for different lysosomal enzymes not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The discovery that CLN8 interacts with PP2A and its inhibitor I2PP2A, with CLN8 deficiency increasing PP2A activity and reducing Akt/S6K/GSK3β phosphorylation, provided a signaling axis linking CLN8 to cell survival regulation independent of its cargo receptor role.\",\n      \"evidence\": \"Co-IP of CLN8–PP2A/I2PP2A, phospho-western blotting, pharmacological rescue with cantharidin in patient fibroblasts\",\n      \"pmids\": [\"30453012\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relationship between PP2A regulation and lysosomal enzyme trafficking not clarified\", \"Single-lab observation\", \"Whether PP2A interaction is direct or bridged through a common complex unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstration that CLN6 and CLN8 form an obligate complex (EGRESS) that jointly recruits lysosomal enzymes at the ER resolved how ER cargo reception is organized; epistasis analysis in double-KO mice confirmed they act in the same pathway.\",\n      \"evidence\": \"Reciprocal co-IP, CLN6 luminal loop mutagenesis, trafficking assays, CLN6/CLN8 double-knockout mice\",\n      \"pmids\": [\"32597833\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and structure of the EGRESS complex unknown\", \"How EGRESS distinguishes different lysosomal enzymes from other ER cargo not defined\", \"Whether additional ER factors participate in the complex\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"CLN8 knockdown in primary neurons caused Golgi expansion, altered endo-lysosome dynamics, lysosomal alkalinization, and dendritic atrophy, providing a cellular phenotype linking CLN8 loss to neuronal morphology defects.\",\n      \"evidence\": \"siRNA knockdown with live-cell LAMP1-pHluorin imaging and dendritic morphometry in rat hippocampal neurons\",\n      \"pmids\": [\"34021618\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether Golgi expansion is a direct consequence of impaired ER-to-Golgi trafficking or secondary\", \"No rescue experiment reported\", \"Mechanism of dendritic simplification not established\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"CLN8 dysfunction was shown to impair autophagy in vivo, and pharmacological enhancement of autophagy with trehalose/SG2 attenuated pathology in CLN8-deficient zebrafish, establishing autophagy as a therapeutically relevant downstream pathway.\",\n      \"evidence\": \"CLN8 loss-of-function zebrafish model with autophagy analysis and pharmacological rescue\",\n      \"pmids\": [\"38763444\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular step at which autophagy is blocked not defined\", \"Whether autophagy impairment is secondary to lysosomal enzyme depletion or an independent function of CLN8\", \"Relevance to mammalian disease models not yet tested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Biochemical reconstitution demonstrated that CLN8 is a lysophosphatidylglycerol acyltransferase catalyzing a critical step in BMP biosynthesis, revealing for the first time a direct enzymatic activity for CLN8 and explaining its requirement for lysosome membrane lipid homeostasis.\",\n      \"evidence\": \"In vitro acyltransferase assay with substrate/product identification by lipidomics\",\n      \"pmids\": [\"39970228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How acyltransferase activity is coordinated with the EGRESS cargo receptor function is unknown\", \"Structural basis of dual function not resolved\", \"Whether BMP deficiency or enzyme depletion is the primary driver of NCL pathology remains open\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how CLN8 integrates its dual roles as an acyltransferase for BMP biosynthesis and as an ER cargo receptor within the EGRESS complex, whether these functions are separable, and which activity is the primary driver of neurodegeneration in NCL.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structure of CLN8 or the EGRESS complex\", \"Relative contribution of BMP deficiency vs. lysosomal enzyme depletion to disease not dissected\", \"Cell-type-specific functions in neurons vs. glia not resolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [13]},\n      {\"term_id\": \"GO:0038024\", \"supporting_discovery_ids\": [8, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1, 3, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0009536\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [12]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [8, 10]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [5, 13]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [8, 10, 11]}\n    ],\n    \"complexes\": [\"EGRESS complex (CLN6-CLN8)\"],\n    \"partners\": [\"CLN6\", \"VAPA\", \"GABARAPL2\", \"PP2A\", \"I2PP2A\", \"BNIP3L\", \"STX8\"],\n    \"other_free_text\": []\n  }\n}\n```\n\nWait, I need to fix the pathway section - I accidentally included GO:0009536 (plastid) which is nonsensical. Let me correct:\n\n```json\n{\n  \"mechanistic_narrative\": \"CLN8 is an ER-resident transmembrane protein that serves dual roles as a lysophosphatidylglycerol acyltransferase essential for bis(monoacylglycero)phosphate (BMP) biosynthesis and as an ER cargo receptor for lysosomal enzymes, thereby governing lysosome biogenesis and function [PMID:39970228, PMID:30397314]. CLN8 forms the EGRESS complex with CLN6, which recruits soluble lysosomal enzymes at the ER via its second luminal loop and mediates their COPII/COPI-dependent export to the Golgi; disease-causing mutations in this loop abolish enzyme binding and deplete lysosomal enzymes [PMID:30397314, PMID:32597833]. CLN8 also interacts with PP2A/I2PP2A to regulate ceramide levels and downstream Akt/S6K/GSK3β signaling, and its loss impairs mitochondrial calcium buffering, autophagy, and neuronal viability [PMID:30453012, PMID:21917311, PMID:38763444]. Loss-of-function mutations in CLN8 cause neuronal ceroid lipofuscinosis (Batten disease), a neurodegenerative lysosomal storage disorder [PMID:10508524].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Positional cloning identified CLN8 as a novel transmembrane protein whose mutations cause progressive epilepsy with mental retardation (EPMR) in humans and motor neuron degeneration in mnd mice, establishing CLN8 as a neuronal ceroid lipofuscinosis gene.\",\n      \"evidence\": \"Positional cloning and mutation screening in human EPMR families and mnd mice\",\n      \"pmids\": [\"10508524\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Protein function entirely unknown at this stage\", \"Subcellular localization not determined\", \"No mechanistic connection to lipofuscin storage\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Determination that CLN8 is an ER-resident protein recycling through the ERGIC via a C-terminal KKRP retrieval signal established the ER as its primary site of action and suggested involvement in ER-to-Golgi trafficking.\",\n      \"evidence\": \"Confocal immunofluorescence, pulse-chase, site-directed mutagenesis of KKRP motif\",\n      \"pmids\": [\"10861296\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cargo being trafficked unknown\", \"Enzymatic activity not addressed\", \"Neuronal localization not yet confirmed\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Confirmation of ER localization in primary hippocampal neurons, and the finding that disease mutations do not mislocalize CLN8, indicated that pathogenesis arises from loss of CLN8 function rather than mislocalization.\",\n      \"evidence\": \"Viral expression in primary neurons, subcellular fractionation of mouse brain\",\n      \"pmids\": [\"15160397\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional activity of CLN8 at the ER still unknown\", \"Brain fractionation placed endogenous Cln8 in non-ER light membranes, suggesting additional compartments\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Two parallel discoveries linked CLN8 to ceramide metabolism and to mitochondrial calcium handling: CLN8-deficient cells showed reduced ceramide synthase activity and decreased ceramide species, while Cln8mnd neurons exhibited impaired mitochondrial Ca²⁺ uptake, revealing downstream consequences of CLN8 loss.\",\n      \"evidence\": \"Mass spectrometry lipidomics and co-IP with ceramide synthase; patch-clamp and Ca²⁺ imaging in Cln8mnd hippocampal neurons\",\n      \"pmids\": [\"23160995\", \"21917311\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether CLN8 directly catalyzes ceramide synthesis or acts indirectly was unclear\", \"Relationship between ceramide deficiency and mitochondrial Ca²⁺ defect not established\", \"Single-lab findings for each\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identification of CLN8 physical interactors including VAPA, GATE16/GABARAPL2, and BNIP3/BNIP3L expanded the functional network to ER–organelle contacts and autophagy-related pathways.\",\n      \"evidence\": \"Split-ubiquitin membrane yeast two-hybrid screen validated by co-IP and co-localization in mammalian cells and CNS tissue\",\n      \"pmids\": [\"23142642\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional significance of VAPA and GATE16 interactions not tested by loss-of-function\", \"Y2H-derived interactions require further in vivo validation\", \"No direct link to lysosomal enzyme trafficking yet\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"A breakthrough study revealed CLN8 functions as an ER cargo receptor for lysosomal enzymes, with its second luminal loop directly binding enzymes and its cytosolic C-terminus engaging COPII/COPI machinery; this explained how CLN8 loss depletes lysosomes of soluble enzymes and impairs lysosome biogenesis.\",\n      \"evidence\": \"Co-IP, mutagenesis of export/retrieval signals and luminal loop, CLN8 KO/KD with lysosomal enzyme quantification and trafficking assays\",\n      \"pmids\": [\"30397314\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CLN8 acts alone or requires a co-receptor was unknown\", \"Enzymatic activity of CLN8 itself not addressed\", \"Selectivity mechanism for different lysosomal enzymes not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The discovery that CLN8 interacts with PP2A and its inhibitor I2PP2A, with CLN8 deficiency increasing PP2A activity and reducing Akt/S6K/GSK3β phosphorylation, provided a signaling axis linking CLN8 to cell survival regulation independent of its cargo receptor role.\",\n      \"evidence\": \"Co-IP of CLN8–PP2A/I2PP2A, phospho-western blotting, pharmacological rescue with cantharidin in patient fibroblasts\",\n      \"pmids\": [\"30453012\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relationship between PP2A regulation and lysosomal enzyme trafficking not clarified\", \"Single-lab observation\", \"Whether PP2A interaction is direct or bridged through a common complex unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstration that CLN6 and CLN8 form an obligate complex (EGRESS) that jointly recruits lysosomal enzymes at the ER resolved how ER cargo reception is organized; epistasis analysis in double-KO mice confirmed they act in the same pathway.\",\n      \"evidence\": \"Reciprocal co-IP, CLN6 luminal loop mutagenesis, trafficking assays, CLN6/CLN8 double-knockout mice\",\n      \"pmids\": [\"32597833\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and structure of the EGRESS complex unknown\", \"How EGRESS distinguishes different lysosomal enzymes from other ER cargo not defined\", \"Whether additional ER factors participate in the complex\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"CLN8 knockdown in primary neurons caused Golgi expansion, altered endo-lysosome dynamics, lysosomal alkalinization, and dendritic atrophy, providing a cellular phenotype linking CLN8 loss to neuronal morphology defects.\",\n      \"evidence\": \"siRNA knockdown with live-cell LAMP1-pHluorin imaging and dendritic morphometry in rat hippocampal neurons\",\n      \"pmids\": [\"34021618\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether Golgi expansion is a direct consequence of impaired ER-to-Golgi trafficking or secondary\", \"No rescue experiment reported\", \"Mechanism of dendritic simplification not established\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"CLN8 dysfunction was shown to impair autophagy in vivo, and pharmacological enhancement of autophagy with trehalose/SG2 attenuated pathology in CLN8-deficient zebrafish, establishing autophagy as a therapeutically relevant downstream pathway.\",\n      \"evidence\": \"CLN8 loss-of-function zebrafish model with autophagy analysis and pharmacological rescue\",\n      \"pmids\": [\"38763444\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular step at which autophagy is blocked not defined\", \"Whether autophagy impairment is secondary to lysosomal enzyme depletion or an independent function of CLN8\", \"Relevance to mammalian disease models not yet tested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Biochemical reconstitution demonstrated that CLN8 is a lysophosphatidylglycerol acyltransferase catalyzing a critical step in BMP biosynthesis, revealing for the first time a direct enzymatic activity for CLN8 and explaining its requirement for lysosome membrane lipid homeostasis.\",\n      \"evidence\": \"In vitro acyltransferase assay with substrate/product identification by lipidomics\",\n      \"pmids\": [\"39970228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How acyltransferase activity is coordinated with the EGRESS cargo receptor function is unknown\", \"Structural basis of dual function not resolved\", \"Whether BMP deficiency or enzyme depletion is the primary driver of NCL pathology remains open\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how CLN8 integrates its dual roles as an acyltransferase for BMP biosynthesis and as an ER cargo receptor within the EGRESS complex, whether these functions are separable, and which activity is the primary driver of neurodegeneration in NCL.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structure of CLN8 or the EGRESS complex\", \"Relative contribution of BMP deficiency vs. lysosomal enzyme depletion to disease not dissected\", \"Cell-type-specific functions in neurons vs. glia not resolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [13]},\n      {\"term_id\": \"GO:0038024\", \"supporting_discovery_ids\": [8, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1, 3, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [12]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [8, 10]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [5, 13]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [8, 10, 11]}\n    ],\n    \"complexes\": [\"EGRESS complex (CLN6-CLN8)\"],\n    \"partners\": [\"CLN6\", \"VAPA\", \"GABARAPL2\", \"PP2A\", \"I2PP2A\", \"BNIP3L\", \"STX8\"],\n    \"other_free_text\": []\n  }\n}\n```"}